Biotech business model with early profitability & higher economic success. Product developed from concept in healthy human adults.
Focus: Develop non-regulated & regulated drugs for pre-diabetes-an healthy adult metabolic condition.Left unattended increases chances of developing diabetes, obesity, heart attack, stroke & premature aging. Market: 200 million adults. Technology developed. Main feature : Compound developed using healthy human adults not animals. Non-regulated product ready for market launch. Quicker payoffs, rapid drug commercialization.